(Q84059601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lucia Mancinelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Riccardo Sarzani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Alessia Buglioni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Eliana Franchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Paolo Dessì-Fulgheri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

3 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

818-826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Blood-pressure-related disease is a global health priority

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

A novel adipokine CTRP1 stimulates aldosterone production

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

The incidence and implications of aldosterone breakthrough

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: possible involvement of bone morphogenetic protein-6 actions

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Predictive validity of a medication adherence measure in an outpatient setting

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Novel use of Kaplan-Meier methods to explain age and gender differences in hypertension control rates

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Does aldosterone modulate central control of blood pressure?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Aldosterone in salt-sensitive hypertension and metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Additive effects of losartan and enalapril on blood pressure and plasma active renin

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Body mass index predicts aldosterone production in normotensive adults on a high-salt diet

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

A not-so-modest proposal that a "modest" increase in aldosterone causes hypertension and more

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Mechanisms of angiotensin II formation in humans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin–angiotensin–aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Spironolactone management of resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2012.47

7 January 2021

Identifiers

DOI

10.1038/AJH.2012.47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22552267%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference